{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:58:28Z","timestamp":1790132308032,"version":"4.0.1"},"reference-count":24,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1392,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1111\/j.1365-2265.2011.04109.x","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T09:00:29Z","timestamp":1305882029000},"page":"811-818","source":"Crossref","is-referenced-by-count":28,"title":["Reduced levels of E-cadherin correlate with progression of corticotroph pituitary tumours"],"prefix":"10.1111","volume":"75","author":[{"given":"Johan Arild","family":"Evang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Petter","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivera","family":"Casar-Borota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tove","family":"Lekva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Kristiansen","family":"Kringen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Ramm-Pettersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Bollerslev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,11,9]]},"reference":[{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1210\/jc.83.5.1619","article-title":"Biochemical assessment of Cushing\u2019s disease in patients with corticotroph macroadenomas","volume":"83","author":"Katznelson","year":"1998","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1530\/eje.0.1380153","article-title":"Cushing\u2019s disease: a comparison of pituitary corticotroph microadenomas and macroadenomas","volume":"138","author":"Selvais","year":"1998","journal-title":"European Journal of Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1210\/jc.2005-0070","article-title":"Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas","volume":"90","author":"Woo","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0002-9440(10)64725-6","article-title":"Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors: comparison between micro- and macroadenomas","volume":"156","author":"Losa","year":"2000","journal-title":"American Journal of Pathology"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archinte.1978.03630280045017","article-title":"Incidence of pituitary tumors following adrenalectomy. A long-term follow-up study of patients treated for Cushing\u2019s disease","volume":"138","author":"Cohen","year":"1978","journal-title":"Archives of Internal Medicine"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.7326\/0003-4819-85-6-731","article-title":"Nelson\u2019s syndrome: frequency, prognosis, and effect of prior pituitary irradiation","volume":"85","author":"Moore","year":"1976","journal-title":"Annals of Internal Medicine"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1530\/EJE-10-0466","article-title":"Nelson\u2019s syndrome","volume":"163","author":"Barber","year":"2010","journal-title":"European Journal of Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/aja.1000410206","article-title":"The development of the hypophysis cerebri of the albino rat","volume":"41","author":"Schwind","year":"1928","journal-title":"The American Journal of Anatomy"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2004.06.006","article-title":"Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis","volume":"117","author":"Yang","year":"2004","journal-title":"Cell"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.molmed.2008.03.004","article-title":"Epithelial-mesenchymal transition and the invasive potential of tumors","volume":"14","author":"Gavert","year":"2008","journal-title":"Trends in Molecular Medicine"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1210\/jc.2009-2197","article-title":"The expression of E-cadherin in somatotroph pituitary adenomas is related to tumor size, invasiveness, and somatostatin analog response","volume":"95","author":"Fougner","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1210\/jc.2008-2075","article-title":"Nuclear accumulation of e-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomas","volume":"94","author":"Elston","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2265.2010.03805.x","article-title":"HDAC2 expression and variable number of repeats in exon 1 of the HDAC2 gene in corticotroph adenomas","volume":"73","author":"Evang","year":"2010","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1210\/jc.2007-2272","article-title":"Low levels of raf kinase inhibitory protein in growth hormone-secreting pituitary adenomas correlate with poor response to octreotide treatment","volume":"93","author":"Fougner","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/modpathol.3800965","article-title":"Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas","volume":"20","author":"Qian","year":"2007","journal-title":"Modern Pathology"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1385\/EP:13:4:341","article-title":"Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies","volume":"13","author":"Xu","year":"2002","journal-title":"Endocrine Pathology"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1023\/A:1005709014239","article-title":"Expression of epithelial cadherin and cavernous sinus invasion in human pituitary adenomas","volume":"34","author":"Kawamoto","year":"1997","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/01.MP.0000039572.75188.1A","article-title":"Role of E-cadherin, alpha-, beta-, and gamma-catenins, and p120 (cell adhesion molecules) in prolactinoma behavior","volume":"15","author":"Qian","year":"2002","journal-title":"Modern Pathology"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3727\/000000001783992731","article-title":"DNA methylation and histone deacetylation in the control of gene expression: basic biochemistry to human development and disease","volume":"9","author":"El-Osta","year":"2000","journal-title":"Gene Expression"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1158\/1535-7163.MCT-06-0609","article-title":"Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells","volume":"6","author":"Reinhold","year":"2007","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1210\/jc.2009-0595","article-title":"The glucocorticoid-induced leucine zipper gene (GILZ) expression decreases after successful treatment of patients with endogenous Cushing\u2019s syndrome and may play a role in glucocorticoid-induced osteoporosis","volume":"95","author":"Lekva","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1073\/pnas.0801551105","article-title":"Conservation analysis predicts in vivo occupancy of glucocorticoid receptor-binding sequences at glucocorticoid-induced genes","volume":"105","author":"So","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/ng.759","article-title":"Chromatin accessibility pre-determines glucocorticoid receptor binding patterns","volume":"43","author":"John","year":"2011","journal-title":"Nature Genetics"},{"key":"10.1111\/j.1365-2265.2011.04109.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1227\/01.NEU.0000349930.66434.82","article-title":"Ki-67 in pituitary neoplasms: a review - part I","volume":"65","author":"Salehi","year":"2009","journal-title":"Neurosurgery"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2011.04109.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2265.2011.04109.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T22:10:10Z","timestamp":1712441410000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2011.04109.x"}},"subtitle":["<i>E-cadherin in corticotroph tumours<\/i>"],"short-title":[],"issued":{"date-parts":[[2011,11,9]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04109.x","relation":{},"ISSN":["0300-0664"],"issn-type":[{"value":"0300-0664","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11,9]]}}}